Download
https://www.ndtvprofit.com/markets/panacea-biotecs-stock-gains-most-in-10-months-on-deal-to-produce-sputnik-v-vaccine?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Panacea Biotec has signed a pact to produce 100 million doses of Russia’s Sputnik V vaccine in India per year.
Share